This filing is an exhibit (Exhibit 24) detailing a Power of Attorney granted by William P. Scully to Reid E. Buchanan, Diana L. Hayes, and Todd W. Fennell. The attorneys-in-fact are authorized to act on behalf of Mr. Scully in all matters related to his filings with the U.S. Securities and Exchange Commission (SEC). Th...

This filing details a Power of Attorney granted by Andreas Grauer, Chief Medical Officer of Sagimet Biosciences Inc., to David Happel and Elizabeth Rozek. The attorneys-in-fact are authorized to execute and file various SEC forms, including Forms 3, 4, and 5, Schedule 13D, and Schedule 13G, on behalf of Mr. Grauer. Thi...

This filing is a Form 3, which reports initial beneficial ownership of securities. It indicates that Christopher Martin, a director of Achieve Life Sciences, Inc., has no securities beneficially owned following the reporting period. The filing also includes a Limited Power of Attorney document, appointing Sandra Thomso...

This filing relates to a Power of Attorney granted by Owen Hughes, a director of AnaptysBio, Inc., to Daniel Faga and Dave McKeon. The power of attorney authorizes the attorneys-in-fact to execute and file all necessary Form 3, 4, or 5 reports with the SEC and any stock exchange on behalf of Mr. Hughes, in accordance w...

This filing indicates that Christopher M. Murphy, Chief Financial Officer of AnaptysBio, Inc., has appointed Daniel Faga and Dave McKeon as his attorneys-in-fact. This appointment authorizes them to execute and file all necessary Form 3, 4, or 5 reports with the SEC and any stock exchanges on Mr. Murphy's behalf, in ac...